In conclusion, our study highlights Orai3 as a major regulator of cell cycle progression and therefore growth of NSCLC cells and makes it as an interesting potential bio-marker and/or target for adenocarcinoma lung therapy. The gene discussed is ORAI3; the disease is non-small cell lung carcinoma.